logo
#

Latest news with #CathLab

Manipal Hospitals Kolkata completes 50 successful TAVR cases
Manipal Hospitals Kolkata completes 50 successful TAVR cases

The Wire

time3 days ago

  • Health
  • The Wire

Manipal Hospitals Kolkata completes 50 successful TAVR cases

KOLKATA, India, Aug. 12, 2025 /PRNewswire/ -- Manipal Hospitals - EM Bypass (erstwhile Medica Superspecialty Hospital), Kolkata is thrilled to announce the completion of 50 successful Transcatheter Aortic Valve Replacement (TAVR) cases, establishing the facility as a regional market leader in structural cardiac procedures in Eastern India. TAVR is a minimally invasive approach of treating patients with severe aortic stenosis who are at high or prohibitive risk for traditional open-heart surgery. This is more than just a number, it demonstrates a patient's faith, cutting-edge infrastructure, the collaboration of the interdisciplinary heart team, and the unwavering commitment to giving patients a second chance at life. TAVR procedures are now well established and worldwide more than 120,000 patients underwent TAVR in 50 countries. In India, as of now, 5000 procedures have been performed over the last 10 years. In Eastern India, the highest number of TAVR procedures has been performed in Manipal Hospitals. In recognizing this achievement, Dr. Dilip Kumar,Director Cath Lab, Senior Interventional Cardiologist, Device and Structural Heart Expert, Manipal Hospital - EM Bypass, opined, "TAVR is a cardiac care milestone that has transformed the treatment of valve dysfunction in complex instances, particularly in the elderly and high-risk patients. Achieving the 50-case milestone without complications demonstrates not only our team's expertise, but also the patient-centred ecosystem we have established here at the units of Manipal Hospital in Kolkata. Catheter-based valve replacement is becoming the wave of the future in cardiac intervention, and we are proud to be at the forefront, giving world-class outcomes right here in Eastern India." Dr. Arindam Pande, Senior Consultant, Department of Cardiology and Consultant Interventional Cardiologist, Manipal Hospital - EM Bypass shared, "With TAVR, we can provide a life-saving option to patients who previously had very little to choose from. In contrast to conventional surgeries, this one bypasses the opening of the chest and minimizes risks of anaesthesia. Patients usually go home in a day or two, and such a recovery is nothing less than a revolution. This milestone of 50 cases is a testament to the hospital's progressive attitude towards heart care." Manipal Hospital is committed to harness the latest technology and clinical expertise to change lives. The team continues to strive for greater access to TAVR and providing the optimal recovery and quality of life to structural heart disease patients. About Manipal Hospitals: As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multi-specialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds and a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provide comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals are NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys. Logo: (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.). PTI This is an auto-published feed from PTI with no editorial input from The Wire. This article went live on August twelfth, two thousand twenty five, at twenty-two minutes past four in the afternoon.

Manipal Hospitals Kolkata completes 50 successful TAVR cases
Manipal Hospitals Kolkata completes 50 successful TAVR cases

Business Standard

time3 days ago

  • Health
  • Business Standard

Manipal Hospitals Kolkata completes 50 successful TAVR cases

PRNewswire Kolkata (West Bengal) [India], August 12: Manipal Hospitals - EM Bypass (erstwhile Medica Superspecialty Hospital), Kolkata is thrilled to announce the completion of 50 successful Transcatheter Aortic Valve Replacement (TAVR) cases, establishing the facility as a regional market leader in structural cardiac procedures in Eastern India. TAVR is a minimally invasive approach of treating patients with severe aortic stenosis who are at high or prohibitive risk for traditional open-heart surgery. This is more than just a number, it demonstrates a patient's faith, cutting-edge infrastructure, the collaboration of the interdisciplinary heart team, and the unwavering commitment to giving patients a second chance at life. TAVR procedures are now well established and worldwide more than 120,000 patients underwent TAVR in 50 countries. In India, as of now, 5000 procedures have been performed over the last 10 years. In Eastern India, the highest number of TAVR procedures has been performed in Manipal Hospitals. In recognizing this achievement, Dr. Dilip Kumar,Director Cath Lab, Senior Interventional Cardiologist, Device and Structural Heart Expert, Manipal Hospital - EM Bypass, opined, "TAVR is a cardiac care milestone that has transformed the treatment of valve dysfunction in complex instances, particularly in the elderly and high-risk patients. Achieving the 50-case milestone without complications demonstrates not only our team's expertise, but also the patient-centred ecosystem we have established here at the units of Manipal Hospital in Kolkata. Catheter-based valve replacement is becoming the wave of the future in cardiac intervention, and we are proud to be at the forefront, giving world-class outcomes right here in Eastern India." Dr. Arindam Pande, Senior Consultant, Department of Cardiology and Consultant Interventional Cardiologist, Manipal Hospital - EM Bypass shared, "With TAVR, we can provide a life-saving option to patients who previously had very little to choose from. In contrast to conventional surgeries, this one bypasses the opening of the chest and minimizes risks of anaesthesia. Patients usually go home in a day or two, and such a recovery is nothing less than a revolution. This milestone of 50 cases is a testament to the hospital's progressive attitude towards heart care." Manipal Hospital is committed to harness the latest technology and clinical expertise to change lives. The team continues to strive for greater access to TAVR and providing the optimal recovery and quality of life to structural heart disease patients. About Manipal Hospitals: As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multi-specialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds and a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provide comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals are NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys.

Revanna holds meeting with HIMS, Health Dept. officers over sudden deaths in Hassan
Revanna holds meeting with HIMS, Health Dept. officers over sudden deaths in Hassan

The Hindu

time08-07-2025

  • Health
  • The Hindu

Revanna holds meeting with HIMS, Health Dept. officers over sudden deaths in Hassan

Former Minister and Holenarasipur MLA H.D. Revanna, on Tuesday, held a meeting with officers of Hassan Institute of Medical Sciences and the Department of Health and Family Welfare regarding the recent sudden deaths reported in Hassan district. Mr. Revanna told the officers that the people were in shock over a series of deaths due to heart-related ailments. Many private hospitals and clinics have been allegedly using this opportunity to make money by charging high fee for tests. The officers should ensure the government ambulances work throughout the day and do not take patients to private hospitals, he said. He pointed out that the district has a medical college and a super-speciality hospital as well. Given the facilities available, the patients need not go to private hospitals. He also instructed the officials to take action against the doctors who recommend patients to private hospitals. Speaking to press persons, the JD(S) MLA pointed out the absence of a Cath Lab system, an interventional imaging platform helpful to treat people with heart problems, at the HIMS. He said that the system had not been set up even after it was sanctioned and the institute had sufficient funds to procure it. He demanded that the HIMS should conduct Electrocardiogram (ECG) and Echocardiogram (Echo) tests, free of cost, utilising the user's fund of the institute. Citing addiction to alcohol as one of the reasons for heart attacks, Mr. Revanna suggested closing liquor shops by 8 p.m. in Hassan city. Legislators A. Manju, C.N. Balakrishna, H.P. Swaroop, HIMS director B. Rajanna, and DHO Anil Kumar, among others were present at the meeting.

BRIMS's Cath Lab Closure Sparks Outrage Amid Heart Attack Surge In Karnataka's Hassan
BRIMS's Cath Lab Closure Sparks Outrage Amid Heart Attack Surge In Karnataka's Hassan

News18

time02-07-2025

  • Health
  • News18

BRIMS's Cath Lab Closure Sparks Outrage Amid Heart Attack Surge In Karnataka's Hassan

Last Updated: The state-of-the-art Cath Lab at Bidar Institute of Medical Sciences remains unused due to administrative issues, despite rising heart attack cases in Hassan district. Amid rising concerns over spate of heart attacks in Hassan district, people are rushing for screening but the newly-built state-of-the-art Cath Lab at the Bidar Institute of Medical Sciences (BRIMS) is gathering dust. The closure of the Cath Lab has raised serious questions about its administration. The high-tech lab, introduced to cater people from a poor background, has been lying unused for months. This comes amidst allegations that the BRIMS management board got influenced by private hospitals. Bidar city already has five private Cath Labs, and poor patients are struggling to afford their services. Staff Hired For Cath Lab Demand Salary Hike For the past seven to eight months, BRIMS has been dragging its feet on appointing specialist doctors and staff for the lab. While 10 people, including doctors and staff, were hired on a contractual basis on April 3 but reports suggest that they are reluctant to join due to the contractual nature and lower salaries. The appointed staff are demanding permanent positions and BRIMS reportedly seems to be showing indifference towards permanent appointments for cardiologists. Locals are questioning whether BRIMS, the district administration, and elected representatives genuinely care about poor people suffering from heart-related ailments, urging them to resist private hospital influence and open the lab immediately. Sudden Rise In Heart Attacks In Hassan Sparks Concerns A distressing wave of heart attack has gripped Hassan district with 18 deaths reported in a one-month span between May 28 and June 29. At least five more deaths have been reported between June 30 and July 1, pointing to an alarming trend that includes younger victims. In light of this alarming trend, a high-level meeting was called on June 30 at the Hassan District Collector's office. Presided over by the Principal Secretary to the Government, Health & Family Welfare Department, the meeting included key medical professionals such as the Director of Sri Jayadeva Institute of Cardiovascular Sciences, the Hassan District Health and Family Welfare Officer, District Surgeon, Medical Superintendent, and District Surveillance Officer. During the urgent discussions, critical directives were issued to address the crisis. A district-level committee has been mandated to investigate the factual circumstances of each reported heart attack death. Furthermore, an existing expert committee, operating under the chairmanship of the Director of Sri Jayadeva Institute of Cardiovascular Sciences, has been specifically tasked with probing sudden deaths potentially linked to Covid-19 or its vaccine side effects. This committee is expected to submit a comprehensive report within 10 days, aiming to shed light on potential contributing factors.

Silent Epidemic: Shefali Jariwala's Death Sparks Alarm Over Growing Heart Ailments In Young Indians
Silent Epidemic: Shefali Jariwala's Death Sparks Alarm Over Growing Heart Ailments In Young Indians

News18

time30-06-2025

  • Health
  • News18

Silent Epidemic: Shefali Jariwala's Death Sparks Alarm Over Growing Heart Ailments In Young Indians

Last Updated: Data and doctors reveal a deeper and far more widespread crisis: a growing epidemic of cardiovascular disease affecting Indians – not only rich but also poor in far-flung areas. The sudden death of television actress and model Shefali Jariwala, popularly known as the ' Kaanta Laga girl," at the age of 42 due to cardiac arrest has once again stirred public concern over the rising incidence of heart-related ailments in India. While such cases involving young celebrities make headlines, data and doctors reveal a deeper and far more widespread crisis: a growing epidemic of cardiovascular disease affecting Indians – not only rich but also poor in far-flung areas. Heart ailments no more a rich man's disease According to the latest data under the central government's flagship Ayushman Bharat (PM-JAY) scheme, the maximum number of claims are for an angioplasty procedure that involves putting stents in the arteries of the heart to remove blockages, which could prove fatal. The scheme serves as health insurance for the bottom 40 per cent population of India – who are extremely poor and vulnerable, busting the myth that heart ailment is a rich man's disease. The data shows that a whopping Rs 1051 crore has been spent by way of claims under the scheme so far on the procedure named 'PTCA inclusive of diagnostic angiogram'. This is the procedure to perform angioplasty after an angiography is conducted that shows blockages in one's heart. As many as 1.05 lakh patients across the country have undergone this procedure under Ayushman Bharat scheme, implying a spend of Rs 1.05 lakh per patient. In comparison, chronic haemodialysis, though more common with over 15 lakh cases, has led to a lower cumulative spend of Rs 560 crore. The figures clearly indicate that cardiac procedures, though fewer in number, demand significantly higher financial resources — underlining the scale and severity of India's growing heart problem. In fact, several published studies highlight urban versus rural shift of heart ailments. Urban CHD (coronary heart disease) prevalence climbed from roughly 1 per cent in 1960 to 9–10 per cent in 2016 and rural prevalence went from less than 1 per cent to 4–6 per cent, according to a study titled 'Trends in Coronary Heart Disease Epidemiology in India" published in medical journal ScienceDirect. A 9-fold increase in urban CHD over four decades and around 2-fold in rural areas highlights rapid lifestyle transition. 'Five-fold increase in heart procedures" Cardiologists across India are reporting a dramatic surge in cardiac emergencies, especially among young adults. Dr Asit Khanna, Principal Consultant and Director, Cath Lab and Cardiology, Yashoda Super Speciality Hospitals, Kaushambi, told News18, 'The heart-related procedures at my facility have increased 5-fold in 7 years. It was 50 cases in 2018 (when I joined Yashoda), now it's 250 cases per month." Dr Prashant Pawar, Consultant Cardiology at Fortis Hiranandani Hospital, Vashi, also noted a worrying trend. 'Cardiovascular diseases have increased over the past 5 years. On average between 2016-2020, I used to see around 30 to 40 heart attack cases in a month. Over the past 3-4 years I see around 60-70 heart attacks cases in a month. Out of these heart attacks, 30-40 per cent patients are below 40 years and have blood clots (they have more thrombus)," he said. The picture emerging from these accounts is alarming: more young Indians are suffering from heart attacks, and when they do, their condition is often more severe. Supporting this clinical experience is market data from research firm Pharmarack, which confirms that cardiac drugs are now the top-selling segment in India's pharmaceutical market. The segment has grown at a steady 5-year CAGR of 10 per cent, and antihypertensive medications now make up half of all cardiac-related drug sales. What's more concerning is that categories associated with more serious cardiac complications and hospitalisations are growing in double digits. 'Drug sales patterns indicate a disturbing shift in age trends, with cardiac problems increasingly affecting people in the 30–40-year age group, compared to the 50–60-year age bracket in earlier decades," said Sheetal Sapale, vice president, commercial, Pharmarack. The data shows that the sales of heart failure therapies stood at Rs 717 crore in May 2021, which jumped to Rs 1322 crore in May 2025 — almost doubling in four years. India's 'Silent Epidemic' of NCDs The Apollo Hospitals' Health of the Nation 2024 report labels the spike in noncommunicable diseases (NCDs), especially cardiovascular diseases (CVDs), as a 'silent epidemic." According to the report, CVD cases in India jumped from 380 lakh in 2005 to 641 lakh in 2015 — and the number continues to rise. Apollo's annual report 2023-2024 shows that in 2019, lifestyle-linked risks such as unhealthy diet, high blood pressure, high cholesterol, and obesity contributed to 27 per cent of India's total disease burden, compared to 21% in 2010. These risks are directly linked to conditions like ischemic heart disease and stroke. About the Author Himani Chandna Himani Chandna, Associate Editor at CNN News18, specialises in healthcare and pharmaceuticals. With firsthand insights into India's COVID-19 battle, she brings a seasoned perspective. She is particularly More Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! First Published:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store